🇺🇸 FDA
Pipeline program

JS001

JS001-026-III-TNBC

Phase 3 small_molecule completed

Quick answer

JS001 for Triple-Negative Breast Cancer is a Phase 3 program (small_molecule) at Shanghai University of Traditional Chinese Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Shanghai University of Traditional Chinese Medicine
Indication
Triple-Negative Breast Cancer
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials